Dual treatments help PTSD and depression This study is the first randomized control trial to rigorously test a sequential approach to treating comorbid PTSD and major depressive disorder. Feb 4, 2021 0 5
New biomarker may predict which pancreatic cancer patients respond to CD40 immunotherapy Inflammation in the blood could serve as a new biomarker to help identify patients with advanced pancreatic cancer who won't respond to the immune-stimulating drugs known as CD40 agonists, suggests a new study from researchers ... Feb 4, 2021 0 6
COVID-19 vaccine uptake moderately high for residents at skilled nursing facilities Moderately high COVID-19 vaccine coverage was achieved for residents at skilled nursing facilities (SNFs) during the first month of a program to facilitate on-site vaccination of residents and staff members, according to ... Feb 4, 2021 0 2
First federal COVID vaccination sites to open in California The first COVID-19 vaccination sites run by the federal government will be opened in California as the Biden administration employs yet another tool to try to tame the coronavirus pandemic. Feb 4, 2021 0 2
If control measures are stopping flu in its tracks, why aren't they stopping coronavirus? As the COVID-19 pandemic rages, other respiratory illnesses have been unusually quiet this year. Fears of a dangerous influenza and COVID-19 "syndemic" have not come to pass as influenza cases reached some of the lowest rates ... Feb 4, 2021 1 4
Oncology clinical trials decline during pandemic The COVID-19 pandemic was associated with a 60 percent decrease in the number of launches of oncology clinical trials of drugs and biologic therapies, according to a research letter published online Jan. 27 in JAMA Network ... Feb 4, 2021 0 2
Full functionality after hip fracture takes two to three years Hip fracture survivors experience notable declines in function and well-being in the first year after a hip fracture compared with peers without fracture, according to a study published in the January issue of the Journal ... Feb 4, 2021 0 5
AstraZeneca vaccine guards against severe COVID-19 illness New data show that the vaccine developed by the University of Oxford and AstraZeneca not only protects people from serious illness and death, but also slows the transmission of the virus. The Oxford researchers say their ... Feb 4, 2021 0 2
Israel leads world in COVID vaccinations, but challenges remain Israel has become the world leader in COVID-19 vaccine rollouts, inoculating millions of its citizens against the coronavirus in a matter of weeks. Feb 4, 2021 0 3
Using a smartwatch to help detect the progression of Parkinson's disease A team of engineers from Apple Inc. working with researchers from several institutions in the U.S. has found that smartwatches could provide a valuable resource in helping to track the progression of Parkinson's disease in ... Feb 4, 2021 report 0 91
